Topic
ARA-290
Everything we've written on ARA-290 — 6 articles covering the mechanism, the evidence, comparisons, and practical considerations.
6 articles
Immune modulationWhat people are reporting about ARA-290This article summarizes experiences reported in public online communities including Reddit, longevity forums, and discussion boards. We are not advocating human use of any compound discussed here. Many of the peptides discussed are not FDA-approved for the uses described, and some are explicitly not approved for human or veterinary use. What follows is a synthesis of what people have reported, presented to give readers context on the public conversation — not as guidance, not as evidence of safety or efficacy, and not as a recommendation. Decisions about any compound should be made with a qualified prescribing provider after a full medical evaluation.8 min readRecovery and inflammationARA-290 — the erythropoietin fragment that doesn't make red blood cellsThe drug that saves you during a heart attack also, it turns out, does something your bone marrow was never involved in. Doctors have known for decades that erythropoietin — the hormone produced by the kidneys in response to low oxygen — does more than stimulate red blood cell production. When someone has a stroke or a myocardial infarction, tissues that should die don't, sometimes, if EPO levels are high enough. The mechanism for why stayed murky for a long time. The therapeutic question it raised was harder: if EPO can protect tissue, why not use it for that?8 min readRecovery and inflammationARA-290 for neuropathic pain — what limited human research has exploredThe burning starts at your feet, usually. Not the burning of something hot — the burning of something wrong, like the nerves themselves have been set alight from the inside. You pull back the covers at night because the weight of a sheet on your skin is unbearable. You step onto the bathroom tile in the morning and the cold feels like an electric shock. Your neurologist runs a nerve conduction study and tells you the results are normal, which feels like being told you're imagining it. The results were normal because nerve conduction studies measure large, myelinated fibers — the ones responsible for motor function and vibration sense — and what's actually damaged in small-fiber neuropathy are the thin, unmyelinated C-fibers and the lightly myelinated A-delta fibers that nobody measured.8 min readRecovery and inflammationPeptides for chronic pain — what research has explored across nociceptive, neuropathic, and centralized painThe pain has been there for two years. Or five. You've done the rounds — the anti-inflammatory, the physical therapy, the specialist who ordered the imaging, the other specialist who looked at the imaging and said it didn't explain the severity of what you're describing. The medications help a little, or helped for a while, or helped until the side effects became their own problem. You are not in crisis. You are also not okay. You have learned to structure your day around what you can and cannot do, which is a kind of adaptation but not the same as getting better.10 min readImmune modulationPeptides for kidney health — from microvascular protection to acute injury researchThe kidneys do their failing quietly for a very long time. A person can lose half of their functional kidney capacity before any symptoms appear — before they feel the fatigue, the fluid retention, the impaired sleep, the subtle cognitive dulling that characterizes advancing chronic kidney disease. The organ's reserve is substantial and its adaptation mechanisms are sophisticated. But this silence is also why chronic kidney disease often presents late, when the window for intervention has narrowed and the trajectory toward dialysis or transplant may already be set. An estimated 37 million Americans live with chronic kidney disease, and the majority don't know it.10 min readRecovery and inflammationBPC-157 vs TB-500 vs Thymosin Beta-4 vs ARA-290 — the regenerative peptide fieldYou hurt something and it's not getting better. Not dramatically — not torn-tendon surgery territory — but the kind of injury that sits at 60 percent for months, that flares when you push it, that has accumulated enough frustrating physiology-appointments and marginal improvements that you've started looking at the literature yourself. Or maybe it's the gut: a chronically inflamed GI tract that confounds every elimination diet and sits there as a low-grade interference in your life. You've heard that some peptides are researched specifically for tissue repair. You've encountered four names in particular — BPC-157, TB-500, Thymosin Beta-4, ARA-290 — and you want to understand what each actually does before you bring any of them into a clinical conversation.9 min read